Innovation Pharmaceuticals Inc (IPIX)

[petemantx]

Right now the Brilacidin Covid trial has been painted a total failure when in fact all they failed was the primary objective and that failure,IMO, was due more to the weak dosage allowed and the limited days of dosings. So I would say the failure should more accurately be said to have been in the trial setup. I blame this setup on the FDA considering the AMA published a paper last April/May that said Covid therapeutic trials were about 95% run at lower dosages than those needed to provide any effectiveness. For some reason the FDA has had it in for therapeutics from the get go regarding Covid and IMO this shows some government officials are being paid off quite handsomely by BP.

Some will greatly disagree with my assessment. We will see who is right when the complete trial data is released. Though the secondary data may be limited in efficacy due to the low dosage I believe the Compassionate Use data will affirm B was effective according to many markers seen in the CU patients such that it should be continued to be studied for further investigation and use at much higher dosing.

Brilacidin is still worth a fortune IMO and maybe the strongest broad spectrum antiviral ever developed, mainly due to its great anti-inflammatory properties and unique multiple MOAs.

What we need IMO is a strong Covid partner to be able to quickly advance it thru the FDA system and help with the costs. Leo tried to do it alone and to date has been highly unsuccessful. Now is the time to get a strong partner and let both them and IPIX share in the financial bonanza B should cause to occur relating to Covid. The world will be much the better when B gets commercialized. Stockholders have been left hanging much, much too long IMO. Get things done now or get new direction at the top.